About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy
By
Ajith Nair
9 Videos
FEATURING
Ajith Nair
102 views
January 28, 2024
An brief update on cardiac myosin inhibitors for oHCM
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
13:58
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)
Feat.
J. Thomas Heywood
06:23
CVRx | Barostim
ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…
Feat.
W. Abraham,
F. Arribas,
M. Zile
11:49
CVRx | Barostim
ESC 2023: Unmet needs and opportunities with device therapies of HFr…
Feat.
W. Abraham
06:16
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT
Feat.
D. Yaranov
40:17
American College of Cardiology
Heart Failure with Preserved Ejection Fraction: Current Perspectives…
Feat.
S. Shah
14:18
CCM® Therapy
The CCM Solution: How Does it Work and What Does it Do?
Feat.
N. Varma
28:03
Houston Methodist DeBakey Heart and Vascular Center
How to Detect and Treat Heart Failure with Preserved Ejection Fracti…
16:11
Jeffrey Weitz
Extended Anticoagulation for VTE
11:50
American Heart & Vascular Institute
New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …
Feat.
M. Kittleson
19:30
American Heart & Vascular Institute
ISCHEMIA Trial: Are We Overusing Cardiac Stents? Is Revascularizatio…
Feat.
B. Reddy
13:08
Piedmont's Marcus Heart Valve Center
Obstructive Hypertrophic Cardiomyopathy vs. Primary Mitral Valve Pro…
Feat.
R. Martin,
F. Milla
12:21
CVRx | Barostim
Baroreflex Activation Therapy Overview of Clinical Data
Feat.
L. Tsao
20:10
ACC 2024 Insights
ACC 2024 Insights: PVC Burden and Its Temporal Variability - 24/48 H…
Feat.
J. Cheung
54:29
Terumo Interventional Systems
Re-thinking Patient-Centered Care in Cardiology-Heart Failure Evalua…
Feat.
J. Spertus
12:14
CVRx | Barostim
HFA 2023: Challenges and Unmet Needs in GDMT for HFrEF
Feat.
J. Lindenfeld
09:54
Mount Sinai
The ISCHEMIA Trial: Are There Differences in Primary and Secondary O…
Feat.
G. Stone
07:54
ACC 2023 Conference Coverage
ACC 2023: Aficamten in Patients with Symptomatic Non-Obstructive Hyp…
Feat.
A. Masri
42:47
Piedmont Heart Institute
Hypertrophic Cardiomyopathy – Contemporary Approach to Diagnosis and…
Feat.
K. Taylor
10:42
CVRx | Barostim
Barostim Clinical Evidence
Feat.
L. Grazette
32:09
Scripps Health: 2019 Third Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension
Right Ventricular Failure: Diagnosis and Management
Feat.
A. Srivastava
